Abstract:OBJECTIVE:Vasoactive intestinal peptide (VIP) is a neuro-peptide that can modulate immunity. Previous studies indicated that VIP can attenuate the deleterious consequences of severe sepsis and septic shock by regulating production of inflammatory cytokines in immune activated cells. The signaling induced by bacterial components occurs primarily through Toll like receptors (TLRs). TLRs have been recognized to play a key role in pathogen recognition and innate immunity. It was convincingly demonstrated that lung is one of early suffered disaster organ and may trigger multiple organ dysfunction syndrome in sepsis. The present study was conducted to investigate the effects of VIP on TLR2/4 mRNA expressions on acute lung injury of endotoxic shock induced by lipopolysaccharide (LPS) in rat.METHOD:Forty Sprague-Dawley rats were randomly divided into 3 groups, i.e., LPS shock group (n = 16), LPS + VIP group (n = 16), and control group (n = 8). LPS shock model was established by LPS (E. coli O(55)B(5) 10 mg/kg) with tail intravenous injection. The rats in LPS + VIP group were given a bolus of 5 nmol VIP intravenous injection follow by LPS. The rats in control group were given normal saline. The rats were sacrificed at 6 h, 24 h after being injected. The lung tissues were collected. The TLR2 mRNA and TLR4 mRNA expressions were detected by RT-PCR from the lung tissues. Pathological changes of the lungs were observed by light microscope and electron microscope 24 h after LPS injection.RESULT:(1) Lung histopathology: the alveolar space was full with leukocyte, necrotic cells, segmental hemorrhage and protein effusion. Partial alveolar space was enlarged, lung interstitial edema were observed in LPS shock group. However, pathological changes of LPS + VIP group were milder than those in LPS shock group. (2) The expressions of TLR2 mRNA and TLR4 mRNA were significantly higher in LPS shock group compared with those of the control group (F = 16.638, P = 0.000; t = 5.876, P = 0.000), TLR2 mRNA and TLR4 mRNA expression on 24 h was down-regulated in LPS + VIP shock subgroup than those in LPS shock subgroup (F = 16.676, P = 0.000; t = 3.946, P < 0.001).CONCLUSION:Expressions of TLR2 mRNA and TLR4 mRNA were up-regulated on LPS induced lung injury in rats. VIP mitigated lung injury induced by LPS, which may be related to TLR2 mRNA and TLR4 mRNA down-regulation of expression. The effect of VIP may suggest a protective mechanism in sepsis. VIP may play a potential protective role in severe infection.

Vasoactive Intestinal Peptide Suppresses Macrophage-Mediated Inflammation by Downregulating Interleukin-17A Expression Via PKA- and PKC-dependent Pathways.

Vasoactive Intestinal Peptide Suppresses the NLRP3 Inflammasome Activation in Lipopolysaccharide-Induced Acute Lung Injury Mice and Macrophages.

Activation of Epac Alleviates Inflammation and Vascular Leakage in LPS-induced Acute Murine Lung Injury.

Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation

Vasoactive Intestinal Peptide Inhibits the Activation of Murine Fibroblasts and Expression of Interleukin 17 Receptor C

[Experiment Treatment of Collagen-Induced Arthritis in Rats with Recombinant Plasmid Containing Vasoactive Intestinal Peptide Gene].

Vasoactive Intestinal Peptide Attenuates Liver Ischemia/reperfusion Injury in Mice Via the Cyclic Adenosine Monophosphate-Protein Kinase a Pathway.

[Effects of Vasoactive Intestinal Peptide on LPS-induced MMP-9 Expression by Alveolar Macrophages in Rats].

Regulatory Effect of Vasoactive Intestinal Peptide on the Balance of Treg and Th17 in Collagen-Induced Arthritis.

Protection of vasoactive intestinal peptide on lung injury induced by endotoxic shock in rats

Vasoactive intestinal peptide stabilizes intestinal immune homeostasis through maintaining interleukin-10 expression in regulatory B cells

[Effects of Vasoactive Intestinal Peptide on Toll-like Receptor (TLR) 2 Mrna and TLR4 Mrna Expression on Acute Lung Injury Induced by Lipopolysaccharide in Rat].

Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury.

Vasoactive Intestinal Peptide Re-Balances TREM-1/TREM-2 Ratio in Acute Lung Injury

Vasoactive Intestinal Peptide Enhances TNF-α-Induced IL-6 and IL-8 Synthesis in Human Proximal Renal Tubular Epithelial Cells by NF-κB-Dependent Mechanism

Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide

[Influence of Vasoactive Intestinal Peptide on Expression of Pulmonary Surfactant Associated Protein A in Lung Explants].

Vasoactive Intestinal Peptide Inhibits Adhesion Molecule Expression in Activated Human Colon Serosal Fibroblasts by Preventing NF-κB Activation

Vasoactive Intestinal Peptide Represses Activation Of Tumor-Associated Macrophages In Gastric Cancer Via Regulation Of Tnf Alpha, Il-6, Il-12 And Inos

Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.

Vasoactive intestinal peptide alleviates osteoarthritis effectively via inhibiting NF-κB signaling pathway